Literature DB >> 7574326

Adjuvant therapy for pituitary adenomas: the possible role of photodynamic therapy.

P V Marks1.   

Abstract

Although benign, pituitary adenomas may not always be curable by surgery alone. This is usually owing to dural infiltration and the technical problems of removal of involved dura in the sellar region. In such circumstances, some form of adjuvant therapy may be needed to address residual tumour and forestall recurrence. Radiotherapy and drugs, such as bromocriptine or octreotide, although effective are far from ideal adjuvant therapies and this has led to the study of the effects of photodynamic therapy on pituitary adenomas. It has been shown that photodynamic therapy using the photosensitising drugs haematoporphyrin derivative and aluminium phthalocyanine is active experimentally against these tumours. This could provide another useful weapon to use against these challenging lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574326      PMCID: PMC2502333     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  20 in total

1.  Extrasellar Extensions of Pituitary Adenomas: (Section of Neurology).

Authors:  G Jefferson
Journal:  Proc R Soc Med       Date:  1940-05

Review 2.  Radiotherapy of pituitary tumors.

Authors:  F E Halberg; G E Sheline
Journal:  Endocrinol Metab Clin North Am       Date:  1987-09       Impact factor: 4.741

3.  Role of a long-acting somatostatin analogue (SMS 201-995) in the treatment of acromegaly.

Authors:  I M Jackson; L B Barnard; P Lamberton
Journal:  Am J Med       Date:  1986-12-22       Impact factor: 4.965

4.  In vitro study of the effect of photodynamic therapy on pituitary adenomas.

Authors:  P V Marks; T Buxton; C E Furneaux
Journal:  Br J Neurosurg       Date:  1993       Impact factor: 1.596

5.  Studies on the mechanism of tumor destruction by photoradiation therapy.

Authors:  B W Henderson; T J Dougherty; P B Malone
Journal:  Prog Clin Biol Res       Date:  1984

6.  Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study.

Authors:  E R Laws; D A Cortese; J H Kinsey; R T Eagan; R E Anderson
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

7.  Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.

Authors:  J S Bevan; C B Adams; C W Burke; K E Morton; A J Molyneux; R A Moore; M M Esiri
Journal:  Clin Endocrinol (Oxf)       Date:  1987-05       Impact factor: 3.478

8.  Photosensitization of human glioma cells by chalcogenapyrylium dyes.

Authors:  S K Powers; D L Walstad; J T Brown; M Detty; P J Watkins
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

9.  Dural invasion by pituitary tumours.

Authors:  O M Shaffi; P Wrightson
Journal:  N Z Med J       Date:  1975-04-23

10.  Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumors.

Authors:  M Thorén; T Rähn; W Y Guo; S Werner
Journal:  Neurosurgery       Date:  1991-11       Impact factor: 4.654

View more
  1 in total

1.  Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.

Authors:  Chad D Cole; James K Liu; Xiaoming Sheng; Steven S Chin; Meic H Schmidt; Martin H Weiss; William T Couldwell
Journal:  J Neurooncol       Date:  2008-01-29       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.